Cargando…
SANTAVAC(TM): Summary of Research and Development
SANTAVAC is an antigen composition developed via proteomics and cell culture technology that is intended for the development of cancer vaccines against various solid tumors. Its mechanism of action is based on the heterogeneity of endothelial cells, the polypeptides of which are similar to the surfa...
Autores principales: | Lokhov, Petr G., Mkrtichyan, Mikayel, Mamikonyan, Grigor, Balashova, Elena E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963192/ https://www.ncbi.nlm.nih.gov/pubmed/31744189 http://dx.doi.org/10.3390/vaccines7040186 |
Ejemplares similares
-
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2017) -
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
por: Lokhov, Petr G, et al.
Publicado: (2015) -
Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
por: Lokhov, Petr G., et al.
Publicado: (2010) -
Antigenic Essence: Upgrade of Cellular Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2021) -
A Metabolomics Approach to Pharmacotherapy Personalization
por: Balashova, Elena E., et al.
Publicado: (2018)